TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03978884

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Unable to effective arrange trial logistics”

The sponsor’s own words in the registry.

Life of this trial

201920202021Planned start2019-06-01 (planned)Registered2019-06-05Withdrawn (as of)2020-09-03

Vital statistics

Status
Withdrawn
Phase
Phase 4
Sponsor
The University of The West Indies
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus; Hypertension
Interventions
Losartan 50Mg Tab; Losartan/Hydrochlorothiazide 50 Mg-12.5 Mg ORAL TABLET; Losartan/Hydrochlorothiazide 100 Mg-25 Mg ORAL TABLET; Amlodipine 5mg
Participants
0
Sites
1
Countries
Jamaica

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.